SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-007826
Filing Date
2020-11-09
Accepted
2020-11-09 17:28:53
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20200930_10q.htm   iXBRL 10-Q 908449
2 EXHIBIT 31.1 ex_212312.htm EX-31.1 10983
3 EXHIBIT 31.2 ex_212313.htm EX-31.2 11645
4 EXHIBIT 32.1 ex_212314.htm EX-32.1 7171
  Complete submission text file 0001171843-20-007826.txt   3849132

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20200930.xsd EX-101.SCH 30996
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20200930_cal.xml EX-101.CAL 29028
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20200930_def.xml EX-101.DEF 252474
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20200930_lab.xml EX-101.LAB 219535
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20200930_pre.xml EX-101.PRE 268771
10 EXTRACTED XBRL INSTANCE DOCUMENT xbit20200930_10q_htm.xml XML 507533
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 201298854
SIC: 2834 Pharmaceutical Preparations